Exactech, Inc. (EXAC) Downgraded by Robert W

Exactech, Inc. (EXAC) Downgraded by Robert W”

Among 4 analysts covering Exactech (NASDAQ:EXAC), 2 have Buy rating, 0 Sell and 2 Hold. They now have a $42.00 price objective on the medical equipment provider's stock.

Several equities research analysts recently commented on EXAC shares.

Schwab Charles Investment Management Inc. boosted its position in shares of Exactech, Inc. BidaskClub downgraded shares of Exactech from a "hold" rating to a "sell" rating in a report on Monday, July 31st. Zacks upgraded the stock to "Hold" rating in Friday, September 4 report.

The company is so far trading up by 30.78% percent from yesterday's close. With short interest at 116,038 and short average daily volume at 30,690, days to cover is 4.0 and the percentage of shorted shares was 0.01% on September 29. In the past 52 weeks the company's stock price has moved within the range of $22.20 to $34.25. The company's 50 day moving average is $32.18 and its 200-day moving average is $30.28.

Exactech, Inc.'s P/E ratio is 804.81 and market capitalization is 600.46M.

Exactech (NASDAQ:EXAC) last announced its earnings results on Thursday, July 27th.

Wall Street analysts, on average, are forecasting the company's EPS to be 0.24, compared to 0.22 reported in the same quarter previous year. The firm had revenue of $67.30 million for the quarter, compared to analysts' expectations of $67.75 million. The short interest to Exactech Incorporated's float is 1.07%. During the same quarter in the prior year, the firm earned $0.31 EPS.

Recent insider trends for Exactech, Inc. "(EXAC) Receives Consensus Recommendation of "Buy" from Brokerages" was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was stolen and republished in violation of United States and worldwide copyright law.

In other Exactech news, Director Fern Watts sold 1,013 shares of the stock in a transaction on Tuesday, August 8th.

In addition to Gabelli reporting its target price, a total of 3 firms have reported on the stock. Insider ownership increased by a total of 1410 shares, which suggests that EXAC's key executives are feeling more optimistic about the outlook for the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The value of the position overall is up by 6,087.5%. LLC IN lifted its holdings in Exactech by 56.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider's stock worth $278,000 after purchasing an additional 289 shares during the period. JPMorgan Chase & Co. lifted its holdings in Exactech by 2,693.8% during the 1st quarter.

As of the end of the quarter Meeder Asset Management Inc had acquired 248 shares growing its stake by 178.4%. The company's shares were given away at $28.4 per share worth to an income of some $21,215 on account of Binch James G. Majority of Exactech's sales are derived from the target's distribution of extremity implant systems and joint replacement systems for the knee and hip.

Like this


24 October 2017
Photographer Terry Richardson dropped by fashion magazines including Vogue and GQ
He has denied these allegations and stated that, he's "considerate and respectful" of his photography subjects. BuzzFeed News has contacted Richardson for comment.

24 October 2017
Karolina Pliskova kicks off WTA Finals with win over Venus Williams
She failed to win a point on serve as she double-faulted and launched an ill-advised challenge, going down in the tiebreak 7-3. But, her own service faltered yet again as she lost her serve while trying to serve out the set in the 10th game of the set.

24 October 2017
Ex-United star addresses Ozil to Old Trafford rumours
The Germany global has under nine months remaining on his contract with the Gunners and could leave the club for free next summer. The 29-year-old made a poor start to the 2017-18 campaign but put in a dazzling display in Sunday's 5-2 thrashing over Everton .

24 October 2017
Buys 2335 Shares of Cabot Oil & Gas Corporation (COG)
The stock of Cabot Oil & Gas Corporation (NYSE: COG ) has "Underperform" rating given on Wednesday, January 4 by Bank of America. Washington Trust Bancshares reported 0.69% of its portfolio in Applied Materials, Inc. (NYSE:STI) for 119,927 shares.

24 October 2017
JP Morgan Downgrades Rating On Cleveland-Cliffs Inc. (CLF)
BidaskClub raised shares of Cliffs Natural Resources from a hold rating to a buy rating in a report on Thursday, July 6th. Axiom Securities reiterated a "sell" rating on shares of Cliffs Natural Resources in a report on Saturday, November 26th.

24 October 2017
Gears Of War 4's Xbox One X Enhancements Detailed
According to IGN , four Xbox 360 titles will have enhancements specifically for the new gaming system when it arrives next month. The three games that will get fresh enhancements include Halo 3, Fallout 3, Assassin's Creed, and Elder Scrolls IV: Oblivion.

24 October 2017
Lord & Taylor sells its flagship Manhattan store to WeWork
At the meeting, it plans to release proposals for Hudson's Bay, which could include removal of directors, Land & Buildings said. Big chains like Macy's had been under pressure from shareholders to get more value out of their real estate holdings.

24 October 2017
Valero Energy Corporation (VLO) Downgraded by Macquarie to "Neutral"
BidaskClub lowered Valero Energy Corporation from a hold rating to a sell rating in a research report on Wednesday, August 2nd. It fall, as 82 investors sold NKE shares while 439 reduced holdings. 33 funds opened positions while 37 raised stakes.

24 October 2017
Lockheed Martin Corporation (NASDAQ:LMT) To Report Earnings
Farr Miller & Washington Limited Dc holds 0.03% of its portfolio in Lockheed Martin Corporation (NYSE:LMT) for 1,058 shares. It is positive, as 37 investors sold LMT shares while 393 reduced holdings. 1,238,958 shares of the company were exchanged.

24 October 2017
What Are Analysts Opinions On Antares Pharma Inc. (ATRS)
This particular stock's 5-day moving average is 2.14, its 20-day moving average is 3.14 and its 100-day moving average is 3.05. Broadfin Capital LLC owned about 3.07% of Antares Pharma worth $15,467,000 at the end of the most recent reporting period.